OBJECT: Little is known about the epidemiology of meningioma, the most frequently reported primary brain tumor in the US. The authors undertook a case-control study to examine the relationship between family and personal medical history and meningioma risk. METHODS: The authors compared the personal and first-degree family histories of 1124 patients with meningioma (age range 20-79 years) in Connecticut, Massachusetts, North Carolina, the San Francisco Bay Area, and 8 Houston counties between May 1, 2006, and February 26, 2010, and the histories of 1000 control individuals who were frequency-matched for age, sex, and geography. RESULTS: The patients were more likely than the controls to report a first-degree family history of meningioma (OR 4.4, 95% CI 1.6-11.5), and there was an even stronger association in younger cases. The patients were less likely than controls to report immune conditions including allergy (OR 0.6, 95% CI 0.5-0.7) but were more likely to report a history of thyroid cancer (OR 4.7, 95% CI 1.02-21.5) or leukemia (OR 5.4, 95% CI 1.2-24.1) (most after radiotherapy). Among women, patients were more likely than controls to report hormonally related conditions--uterine fibroid tumors (OR 1.2, 95% CI 1.0-1.5), endometriosis (OR 1.5, 95% CI 1.5-2.1), and breast cancer (OR 1.4, 95% CI 0.8-2.3). CONCLUSIONS: The influence of genetics, the immune system, and radiation near the head on meningioma risk is suggested in the authors' findings; the role of hormones is intriguing but requires further study.
OBJECT: Little is known about the epidemiology of meningioma, the most frequently reported primary brain tumor in the US. The authors undertook a case-control study to examine the relationship between family and personal medical history and meningioma risk. METHODS: The authors compared the personal and first-degree family histories of 1124 patients with meningioma (age range 20-79 years) in Connecticut, Massachusetts, North Carolina, the San Francisco Bay Area, and 8 Houston counties between May 1, 2006, and February 26, 2010, and the histories of 1000 control individuals who were frequency-matched for age, sex, and geography. RESULTS: The patients were more likely than the controls to report a first-degree family history of meningioma (OR 4.4, 95% CI 1.6-11.5), and there was an even stronger association in younger cases. The patients were less likely than controls to report immune conditions including allergy (OR 0.6, 95% CI 0.5-0.7) but were more likely to report a history of thyroid cancer (OR 4.7, 95% CI 1.02-21.5) or leukemia (OR 5.4, 95% CI 1.2-24.1) (most after radiotherapy). Among women, patients were more likely than controls to report hormonally related conditions--uterine fibroid tumors (OR 1.2, 95% CI 1.0-1.5), endometriosis (OR 1.5, 95% CI 1.5-2.1), and breast cancer (OR 1.4, 95% CI 0.8-2.3). CONCLUSIONS: The influence of genetics, the immune system, and radiation near the head on meningioma risk is suggested in the authors' findings; the role of hormones is intriguing but requires further study.
Authors: Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt Journal: N Engl J Med Date: 2007-11-01 Impact factor: 91.245
Authors: Nobuko Hijiya; Melissa M Hudson; Shelly Lensing; Margie Zacher; Mihaela Onciu; Fred G Behm; Bassem I Razzouk; Raul C Ribeiro; Jeffrey E Rubnitz; John T Sandlund; Gaston K Rivera; William E Evans; Mary V Relling; Ching-Hon Pui Journal: JAMA Date: 2007-03-21 Impact factor: 56.272
Authors: Kari Hemminki; Steinar Tretli; Jan Sundquist; Tom B Johannesen; Charlotta Granström Journal: Lancet Oncol Date: 2009-04-06 Impact factor: 41.316
Authors: Lara Bethke; Anne Murray; Emily Webb; Minouk Schoemaker; Kenneth Muir; Patricia McKinney; Sarah Hepworth; Polyxeni Dimitropoulou; Artitaya Lophatananon; Maria Feychting; Stefan Lönn; Anders Ahlbom; Beatrice Malmer; Roger Henriksson; Anssi Auvinen; Anne Kiuru; Tiina Salminen; Christoffer Johansen; Helle Collatz Christensen; Michael Kosteljanetz; Anthony Swerdlow; Richard Houlston Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Victoria S Benson; Kirstin Pirie; Jane Green; Diana Bull; Delphine Casabonne; Gillian K Reeves; Valerie Beral Journal: Int J Cancer Date: 2010-10-01 Impact factor: 7.396
Authors: Gabriele Berg-Beckhoff; Joachim Schüz; Maria Blettner; Eva Münster; Klaus Schlaefer; Jürgen Wahrendorf; Brigitte Schlehofer Journal: Eur J Epidemiol Date: 2009-05-31 Impact factor: 8.082
Authors: Elizabeth B Claus; Peter M Black; Melissa L Bondy; Lisa Calvocoressi; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch Journal: Cancer Date: 2007-08-01 Impact factor: 6.860
Authors: Tessa A Harland; Jacob L Freeman; Monica Davern; D Jay McCracken; Emma C Celano; Kevin Lillehei; Jeffrey J Olson; D Ryan Ormond Journal: J Neurooncol Date: 2017-10-28 Impact factor: 4.130
Authors: Elizabeth B Claus; Kyle M Walsh; Lisa Calvocoressi; Melissa L Bondy; Joellen M Schildkraut; Margaret Wrensch; Joseph L Wiemels Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-04-02 Impact factor: 4.254
Authors: Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum Journal: J Neurosurg Date: 2015-01 Impact factor: 5.115
Authors: Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer Journal: Hum Reprod Update Date: 2015-03-11 Impact factor: 15.610
Authors: Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Margaret Wrensch; Joseph L Wiemels; Joellen M Schildkraut Journal: J Neurosurg Date: 2012-10-26 Impact factor: 5.115
Authors: Gabriella M Anic; Melissa H Madden; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; Zachary J Thompson; Shitaldas J Pamnani; Peter A Forsyth; Reid C Thompson; Kathleen M Egan Journal: J Neurooncol Date: 2014-04-04 Impact factor: 4.130